WO2010102528A1 - 防治过敏性呼吸道疾病的方法以及实现该方法的口鼻罩 - Google Patents
防治过敏性呼吸道疾病的方法以及实现该方法的口鼻罩 Download PDFInfo
- Publication number
- WO2010102528A1 WO2010102528A1 PCT/CN2010/070353 CN2010070353W WO2010102528A1 WO 2010102528 A1 WO2010102528 A1 WO 2010102528A1 CN 2010070353 W CN2010070353 W CN 2010070353W WO 2010102528 A1 WO2010102528 A1 WO 2010102528A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mouth
- main
- nose mask
- main cover
- asthma
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 16
- 208000028004 allergic respiratory disease Diseases 0.000 title claims abstract description 10
- 210000002345 respiratory system Anatomy 0.000 claims abstract description 14
- 230000007423 decrease Effects 0.000 claims description 5
- 238000009423 ventilation Methods 0.000 claims description 2
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 230000017525 heat dissipation Effects 0.000 abstract description 2
- 208000006673 asthma Diseases 0.000 description 26
- 201000010099 disease Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 239000007789 gas Substances 0.000 description 13
- 210000001331 nose Anatomy 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000002159 abnormal effect Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000013566 allergen Substances 0.000 description 5
- 230000000172 allergic effect Effects 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010039085 Rhinitis allergic Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 201000010105 allergic rhinitis Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 241000238876 Acari Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010027940 Mood altered Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000007510 mood change Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000010455 vermiculite Substances 0.000 description 2
- 229910052902 vermiculite Inorganic materials 0.000 description 2
- 235000019354 vermiculite Nutrition 0.000 description 2
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030111 Oedema mucosal Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000002200 Respiratory Hypersensitivity Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 230000010085 airway hyperresponsiveness Effects 0.000 description 1
- 210000005091 airway smooth muscle Anatomy 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000005338 heat storage Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011232 storage material Substances 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D13/00—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
- A41D13/05—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
- A41D13/11—Protective face masks, e.g. for surgical use, or for use in foul atmospheres
- A41D13/1107—Protective face masks, e.g. for surgical use, or for use in foul atmospheres characterised by their shape
- A41D13/1138—Protective face masks, e.g. for surgical use, or for use in foul atmospheres characterised by their shape with a cup configuration
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D2400/00—Functions or special features of garments
- A41D2400/10—Heat retention or warming
Definitions
- the invention relates to a method for preventing and treating allergic respiratory diseases and a mouth and nose mask for realizing the same, belonging to the field of disease control in the medical field, mainly for preventing and treating respiratory diseases such as allergic asthma and allergic rhinitis, and also for preventing and treating common colds. effect. Background technique
- Allergic respiratory diseases are frequently afflicted, causing different degrees of harm to human health. Especially allergic respiratory diseases such as asthma and allergic rhinitis have always seriously affected the physical and mental health and quality of life of patients. Asthma is considered to be four.
- One of the major chronic diseases its patients often prolonged unhealed, painful, and even severely died of acute attacks.
- the current methods for the prevention and treatment of such diseases are mainly medical treatment.
- the treatment of asthma is mainly to take hormone drugs and theophylline drugs to relax the airway smooth muscle of patients, to achieve the purpose of restoring airway patency.
- drug treatment such as side effects. Long-term use will lead to drug resistance, which may reduce or even invalidate the drug.
- the theory recognized by the medical community about asthma is that the pathogenesis of asthma is complicated.
- the main causes of the disease are allergens, viral infections, air pollution, climate changes (temperature, humidity, pressure changes), drug allergy, exercise, Mental and emotional factors, etc.
- the main treatments are hormonal drugs to relieve airway obstruction in patients, and long-term medication prevention, through local hot compress and other physical therapy.
- the current theory does not clearly state what is the most important cause of asthma attacks, nor does it recognize the most direct causal relationship between temperature changes (accurately, temperature declines) and asthma (other predisposing factors). It can be considered secondary, and thus does not really recognize that the insulation of the respiratory tract is the fundamental effective means of treating such diseases.
- the inventors have verified through long-term experiments that the respiratory tract warming to patients is a fundamental effective treatment for allergic respiratory diseases such as asthma. Paragraph, and propose new theories about such diseases as follows:
- the cause of asthma is the sudden drop in ambient temperature, which causes the respiratory tract of an allergic body (often highly reactive).
- the stimulation of stimulating factors such as allergens, bacterial microorganisms, exercise, and mood changes produces abnormal abnormal reactions that produce bronchial mucosal edema. Block the airway and block your breathing.
- the cause of allergic rhinitis is that the sudden drop in ambient temperature causes an abnormal abnormal reaction in the nasal mucosa of an allergic body, resulting in edema and obstruction of the nasal cavity.
- the primary and necessary condition for the onset of asthma is the sudden drop in ambient temperature, which is the cause of allergens such as dust mites, microbes, mood changes, etc., which are considered equally important in current medical theory. That is to say, in the environment where there are incentives such as allergens, bacteria, exercise, and mental factors, as long as the ambient temperature does not continue to decrease, people with allergies will not have asthma attacks.
- the sudden drop in temperature mentioned above means that the temperature has continued to decline for a certain period of time, and the slope of the decline continues to be greater than 0 for a period of time, and the patient is prone to morbidity. If the daily temperature curve is drawn, then the time period during which the ⁇ (temperature) curve is falling is theoretically the time period of the asthma attack. The greater the rate of cooling, the longer the duration of cooling, and the more likely it is to trigger an asthma attack. This is a good explanation for why the onset of asthma is always in the autumn, winter, spring, or early morning, and it also explains why in summer, bacterial microbes, mites, etc. are also dense in the air. Asthma patients are almost no disease.
- allergic respiratory diseases such as asthma
- the treatment of allergic respiratory diseases can be simply the only therapeutic target to eliminate the prevalence of sudden drop in ambient temperature.
- the inventors propose that the method for treating such diseases is to eliminate the factor of environmental temperature drop, or to continuously heat the patient's respiratory tract to prevent the environmental temperature from falling on the patient's respiratory tract and causing the disease.
- the drop in ambient temperature you can avoid asthma attacks or recover from a state of attack. If you can't change the temperature in your living environment, you can use moist hot air to keep your respiratory tract warm. It must be free from time and space. Cool down, when to use, cool down Long time, long use time, short cooling time, short use time; when to onset, when to use, serious onset, long use time, mild onset, use time can be shorter.
- the present invention provides a mouth and nose mask, and the invention concept thereof is as follows:
- the exhaled gas of the human body has a certain heat and is harmless to the human body, so that the human body exhaled gas can be utilized.
- the heat is heated to heat the next inhaled air, and the cycle is reciprocated to maintain the user's intake air temperature in a range between about 24 ° C and 30 ° C.
- the nasal mask is a double-layered nasal mask. Its shape and volume are determined according to the face of different patients. The principle is comfortable to wear. There is about 200 ml of gas in the middle of the face and the nose and nose cover.
- the main vent of the nasal mask enters, and enters the hood from the periphery along the gap between the inner and outer layers.
- the exhaled gas also discharges the hood from the same path.
- cold air can be directly impacted on the patient.
- the inhaled cold air is appropriately heated by the heat of the human exhaled gas.
- the steam temperature is controlled at about 30 °C, so that the patient continues to inhale warm steam, after about 1 to 2 hours (must be continuously used continuously;), asthma and other symptoms can be alleviated and gradually Restore If it is normal, if the patient is in a more severe acute attack due to a sudden onset, it is difficult to breathe, and the extended use time can be extended until there is recovery. If the ambient temperature suddenly drops again after recovery, it is necessary to continue using hot steam treatment until the ambient temperature is stable.
- the central portion of the main cover body 1 has a main venting hole 4, the shape and size of which are determined according to the amount of breathing gas of each person, generally circular, and having a diameter of 2 cm to 3 Cm, there may be auxiliary ventilation holes 5 (small round holes with a diameter of about 2 mm) about 3, and the main cover body 1 has a connecting groove 2 for connecting the fixing band 3 for fixing the nasal mask to the head.
- the inner cover 7 is similar in shape to the main cover 1, and the bottom edge of the inner cover 7 is spaced from the person's face to facilitate air circulation, and a connecting rod 8 is disposed between the inner and outer layers.
- the main cover body 1 is connected with a face of the human face with a medical rubber gasket 6 for the user to wear comfortably.
- the air outside the cover is dispersed through the main vent hole to the periphery of the cover, and the gas and heat exhaled by the person are also discharged outside the cover through the edge of the cover, thereby slowing the direct stimulation of the cold air by the cold air.
- the heat dissipation of the exhaled gas is slowed down, and the temperature of the air sucked by the user is maintained in the range of about 24 ° C to 30 ° C.
- the main mask body and the inner layer cover of the nose and mouth mask can be made of medical hard engineering plastics, have a certain thickness, and are durable and not easily deformed.
- the surface of the material in the part of the mouth and nose that is in direct contact with the exhaled gas is selected to be a highly efficient heat storage material, so that the amount of heat exhaled by the person is preserved as much as possible.
- a heating wire may be added inside the inner cover body, and the power is supplied by an alternating current or a direct current power source.
- a sodium peroxide sheet-like patch may be applied to the inside of the inner cover, which consists of a raw material layer, a gelatin layer, and a non-woven bag.
- a mixture of sodium peroxide and a small amount of vermiculite is placed in a non-leakable, air-permeable non-woven bag to form a raw material layer.
- the back side of the stock layer is a gelatin layer for adhering one side to the inside of the main cover.
- Sodium peroxide absorbs carbon dioxide exhaled by humans, exothermic and produces oxygen, and the role of vermiculite is to keep warm. This not only prevents the concentration of carbon dioxide from being high, but also helps to increase the temperature of the gas, and also assists oxygen supply.
- the use of dry sodium hydroxide in tablets also absorbs carbon dioxide and water vapor exhaled by humans.
- a temperature indicator can be added to display the temperature of the gas in the mouth and nose mask.
- the invention has the advantages of: avoiding the limitation of the side effect and the curative effect of the medicine on the human body, safe and effective, strong pertinence, no side effect on the human body, reducing or even eliminating the mortality rate of the asthma patient; clarifying the allergic disease such as asthma The most important cause of the disease is to eliminate the fear and helplessness of the disease for a long time.
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011549420A JP2012517305A (ja) | 2009-03-13 | 2010-01-26 | 過敏性呼吸道疾病の防止方法及びその方法を実現する口鼻マスク |
US13/160,531 US8789531B2 (en) | 2009-03-13 | 2011-06-15 | Mouth and nose mask for preventing and treating allergic respiratory diseases |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100475620A CN101496645B (zh) | 2009-03-13 | 2009-03-13 | 一种保健口鼻罩 |
CN200920068835.5 | 2009-03-13 | ||
CN200920068835U CN201379090Y (zh) | 2009-03-13 | 2009-03-13 | 一种保健口鼻罩 |
CN200910047562.0 | 2009-03-13 | ||
CNA2009100515859A CN101584503A (zh) | 2009-05-20 | 2009-05-20 | 一种防治过敏性呼吸道疾病的方法以及实现该方法的口鼻罩 |
CN200910051585.9 | 2009-05-20 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/160,531 Continuation US8789531B2 (en) | 2009-03-13 | 2011-06-15 | Mouth and nose mask for preventing and treating allergic respiratory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010102528A1 true WO2010102528A1 (zh) | 2010-09-16 |
Family
ID=42727799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2010/070353 WO2010102528A1 (zh) | 2009-03-13 | 2010-01-26 | 防治过敏性呼吸道疾病的方法以及实现该方法的口鼻罩 |
Country Status (3)
Country | Link |
---|---|
US (1) | US8789531B2 (zh) |
JP (1) | JP2012517305A (zh) |
WO (1) | WO2010102528A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112169088A (zh) * | 2020-10-12 | 2021-01-05 | 温州医科大学附属第一医院 | 一种简易面罩喷雾 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014226645B2 (en) * | 2013-03-04 | 2017-04-20 | Fisher & Paykel Healthcare Limited | Patient interfaces with condensation reducing or compensating arrangements |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5331957A (en) * | 1993-02-05 | 1994-07-26 | Liu Chin Chia | Respirator for only filtering air inhaled |
JPH11128378A (ja) * | 1997-10-24 | 1999-05-18 | Uni Charm Corp | 粘着剤を利用したマスク |
CN1462642A (zh) * | 2003-04-08 | 2003-12-24 | 王国欣 | 非典型肺炎预防口罩 |
CN201146847Y (zh) * | 2007-12-07 | 2008-11-12 | 嘉兴市正麒高新面料复合有限公司 | 立体防护面具 |
CN101496646A (zh) * | 2009-03-13 | 2009-08-05 | 李琪 | 一种保健口鼻罩 |
CN101496645A (zh) * | 2009-03-13 | 2009-08-05 | 李琪 | 一种保健口鼻罩 |
CN101496647A (zh) * | 2009-03-13 | 2009-08-05 | 李琪 | 一种保健口鼻罩 |
CN101584503A (zh) * | 2009-05-20 | 2009-11-25 | 李琪 | 一种防治过敏性呼吸道疾病的方法以及实现该方法的口鼻罩 |
CN201360575Y (zh) * | 2009-03-13 | 2009-12-16 | 李琪 | 一种保健口鼻罩 |
CN201360574Y (zh) * | 2009-03-13 | 2009-12-16 | 李琪 | 一种保健口鼻罩 |
CN201379090Y (zh) * | 2009-03-13 | 2010-01-13 | 李琪 | 一种保健口鼻罩 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE20135E (en) * | 1936-10-20 | Hot air respirator | ||
SE7601232L (sv) * | 1976-02-05 | 1977-08-06 | Reboprodukter Goran Segersten | Ansiktsmask med utbytbart filter |
DE2938726C2 (de) * | 1979-09-21 | 1984-10-18 | Auergesellschaft Gmbh, 1000 Berlin | Filtrierende Atemschutzmaske |
US4945907A (en) * | 1987-04-13 | 1990-08-07 | New England Thermoplastics, Inc. | Face mask |
US5094236A (en) * | 1987-04-13 | 1992-03-10 | Better Breathing Inc. | Face mask |
JPH0710773Y2 (ja) * | 1987-06-03 | 1995-03-15 | 株式会社重松製作所 | 簡易マスク |
US4873972A (en) * | 1988-02-04 | 1989-10-17 | Moldex/Metric Products, Inc. | Disposable filter respirator with inner molded face flange |
US4963327A (en) * | 1988-03-23 | 1990-10-16 | Z-Gard, Inc. | Oxygen generating module |
JPH01268568A (ja) * | 1988-04-19 | 1989-10-26 | Danzaburou Takada | 加湿マスク |
US5535736A (en) * | 1995-06-23 | 1996-07-16 | Jzaw; Gwo-Shyong | Inflatable mouthpiece |
US5617849A (en) * | 1995-09-12 | 1997-04-08 | Minnesota Mining And Manufacturing Company | Respirator having thermochromic fit-indicating seal |
US5603317A (en) * | 1996-03-25 | 1997-02-18 | Farmer; Charlene C. | Environmental mask |
US6338340B1 (en) * | 1999-11-02 | 2002-01-15 | Xcaper Industries Llc | Filter mask |
US6817362B2 (en) * | 2001-08-10 | 2004-11-16 | North Safety Products Inc. | Respirator |
SG115600A1 (en) * | 2003-12-31 | 2005-10-28 | Megatech Scientific Pte Ltd | Respiratory mask with inserted spacer |
US7243650B2 (en) * | 2004-07-12 | 2007-07-17 | Thornton W Keith | Custom fitted mask configured for coupling to an external gas supply system and method of forming same |
JP4901142B2 (ja) * | 2005-06-23 | 2012-03-21 | 花王株式会社 | マスク |
-
2010
- 2010-01-26 WO PCT/CN2010/070353 patent/WO2010102528A1/zh active Application Filing
- 2010-01-26 JP JP2011549420A patent/JP2012517305A/ja active Pending
-
2011
- 2011-06-15 US US13/160,531 patent/US8789531B2/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5331957A (en) * | 1993-02-05 | 1994-07-26 | Liu Chin Chia | Respirator for only filtering air inhaled |
JPH11128378A (ja) * | 1997-10-24 | 1999-05-18 | Uni Charm Corp | 粘着剤を利用したマスク |
CN1462642A (zh) * | 2003-04-08 | 2003-12-24 | 王国欣 | 非典型肺炎预防口罩 |
CN201146847Y (zh) * | 2007-12-07 | 2008-11-12 | 嘉兴市正麒高新面料复合有限公司 | 立体防护面具 |
CN101496646A (zh) * | 2009-03-13 | 2009-08-05 | 李琪 | 一种保健口鼻罩 |
CN101496645A (zh) * | 2009-03-13 | 2009-08-05 | 李琪 | 一种保健口鼻罩 |
CN101496647A (zh) * | 2009-03-13 | 2009-08-05 | 李琪 | 一种保健口鼻罩 |
CN201360575Y (zh) * | 2009-03-13 | 2009-12-16 | 李琪 | 一种保健口鼻罩 |
CN201360574Y (zh) * | 2009-03-13 | 2009-12-16 | 李琪 | 一种保健口鼻罩 |
CN201379090Y (zh) * | 2009-03-13 | 2010-01-13 | 李琪 | 一种保健口鼻罩 |
CN101584503A (zh) * | 2009-05-20 | 2009-11-25 | 李琪 | 一种防治过敏性呼吸道疾病的方法以及实现该方法的口鼻罩 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112169088A (zh) * | 2020-10-12 | 2021-01-05 | 温州医科大学附属第一医院 | 一种简易面罩喷雾 |
CN112169088B (zh) * | 2020-10-12 | 2023-04-18 | 温州医科大学附属第一医院 | 一种简易喷雾面罩 |
Also Published As
Publication number | Publication date |
---|---|
US8789531B2 (en) | 2014-07-29 |
US20110240023A1 (en) | 2011-10-06 |
JP2012517305A (ja) | 2012-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110208279A1 (en) | Method and therapeutic apparatus for normalizing function of sinus cilia using heat | |
EP1629859A1 (en) | Face mask | |
US11234861B2 (en) | Respiratory therapeutic electric heat source face mask | |
CN101496645B (zh) | 一种保健口鼻罩 | |
KR101564656B1 (ko) | 소금 마스크 | |
CN101584503A (zh) | 一种防治过敏性呼吸道疾病的方法以及实现该方法的口鼻罩 | |
WO2010102528A1 (zh) | 防治过敏性呼吸道疾病的方法以及实现该方法的口鼻罩 | |
CN101496647A (zh) | 一种保健口鼻罩 | |
US20090277459A1 (en) | Nasal Device Useful for Prevention of Snoring and Sleeping Apnea | |
CN101496646B (zh) | 一种保健口鼻罩 | |
Bach | Respiratory muscle aids for the prevention of pulmonary morbidity and mortality | |
US20140326240A1 (en) | Warming Vapor Pad | |
CN201360575Y (zh) | 一种保健口鼻罩 | |
CN212700129U (zh) | 传染病患者呼吸排放病原体收集、灭活及辅助呼吸设备 | |
CN2510057Y (zh) | 一种能治疗鼻炎的按摩口罩 | |
CN205512486U (zh) | 一种治疗呼吸道疾病的药物口罩 | |
CN113519960A (zh) | 一体式动力送风防护头盔 | |
CN201360574Y (zh) | 一种保健口鼻罩 | |
CN201379090Y (zh) | 一种保健口鼻罩 | |
CN204483135U (zh) | 一种保健口鼻罩 | |
CN110075207A (zh) | 社区居民感冒预防用香囊及其中药组合物 | |
US9717880B2 (en) | Personal airway humidification apparatus and method | |
RU187957U1 (ru) | Термоингалятор | |
CN212650491U (zh) | 一体式动力送风防护头盔 | |
WO2014101365A1 (zh) | 用热空气热敷呼吸道治病的方法和呼吸装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10750324 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011549420 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010750324 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10750324 Country of ref document: EP Kind code of ref document: A1 |